Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Prefrontal correlates of fear generalization during endocannabinoid depletion
Luis E. Rosas-Vidal, Saptarnab Naskar, Leah M. Mayo, Irene Perini, Rameen Masroor, Megan Altemus, Liorimar Ramos-Medina, S. Danyal Zaidi, Hilda Engelbrektsson, Puja Jagasia, Markus Heilig, Sachin Patel
Luis E. Rosas-Vidal, Saptarnab Naskar, Leah M. Mayo, Irene Perini, Rameen Masroor, Megan Altemus, Liorimar Ramos-Medina, S. Danyal Zaidi, Hilda Engelbrektsson, Puja Jagasia, Markus Heilig, Sachin Patel
View: Text | PDF
Research Article Clinical Research Neuroscience

Prefrontal correlates of fear generalization during endocannabinoid depletion

  • Text
  • PDF
Abstract

Maladaptive fear generalization is one of the hallmarks of trauma-related disorders. The endocannabinoid 2-arachidonoylglycerol (2-AG) is crucial for modulating anxiety, fear, and stress adaptation, but its role in balancing fear discrimination versus generalization is not known. To address this, we used a combination of plasma endocannabinoid measurement and neuroimaging in a childhood maltreatment–exposed and –nonexposed mixed population, combined with human and rodent fear-conditioning models. Here we show that 2-AG levels were inversely associated with fear generalization at the behavioral level in both mice and humans. In mice, 2-AG depletion increased the proportion of neurons that respond to, and the similarity of neuronal representations for, both threat-predictive and neutral stimuli within prelimbic prefrontal cortex neuronal ensembles. In humans, increased dorsolateral prefrontal cortical–amygdala resting-state connectivity was inversely correlated with fear generalization. These data provide convergent cross-species evidence that 2-AG is a key regulator of fear generalization and further support the notion that 2-AG deficiency could represent a trauma-related disorder-susceptibility endophenotype.

Authors

Luis E. Rosas-Vidal, Saptarnab Naskar, Leah M. Mayo, Irene Perini, Rameen Masroor, Megan Altemus, Liorimar Ramos-Medina, S. Danyal Zaidi, Hilda Engelbrektsson, Puja Jagasia, Markus Heilig, Sachin Patel

×

Figure 2

Neuronal tone responses in response to NTs and CS+.

Options: View larger image (or click on image) Download as PowerPoint
Neuronal tone responses in response to NTs and CS+.
(A) Schematic of exp...
(A) Schematic of experimental timeline and setup. (B) Sagittal depiction of GRIN lens and microscope implanted above the region where GCaMP7f was expressed in the PL. (C) Left: Example coronal section of the lens track above GCaMP expression in PL. Right: Maximum projection image as seen through the miniaturized microscope, with identified neurons extracted using the CNMFe algorithm surrounded by white lines. (D) Left: Average PL neuronal response to NT for all recorded neurons. Middle: NT response for neurons in PL that exceeded +3 Z-scores during tone presentation. Right: CS+ response for neurons in PL below –3 Z-scores during tone presentation. (E) Left: Average PL neuronal response to conditioned tone (CS+) for all recorded neurons. Middle: CS+ response for neurons in PL that exceed +3 Z-scores during tone presentation. Right. CS+ response for neurons in PL below –3 Z-scores during tone presentation. (F) Top: Pie charts for vehicle- and (G) DO34-exposed mice showing proportion of neurons that significantly responded to tone presentations (±3 Z-scores). Bottom: Proportion of neurons that increased activity to NT [(+) NT] or CS+ [(+) CS+], decreased activity to NT [(–) NT] or CS+ [(–) CS+], or changed activity to both NT and CS+ (dual). (H) Histogram of neuronal stimulus preference strength for NT versus CS+. Hierarchical tree clustering of neuronal activity to NT and CS+ from vehicle- (I) and DO34-exposed (J) mice. Data are shown as mean ± SEM. Repeated-measures ANOVA followed by Šídák’s multiple-comparison test, Fisher’s exact test, and Kolmogorov-Smirnov test where appropriate. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. n = 802 and 885 neurons from n = 7 and 8 mice treated with vehicle and DO34, respectively.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts